Hostname: page-component-7b7567c8c-jswmv Total loading time: 0 Render date: 2026-11-15T20:01:03.205Z Has data issue: false hasContentIssue false

Focal neurocognitive dysfunctions in abstinence delirium: a case report

Published online by Cambridge University Press:  18 September 2015

P. Mariën*
Affiliation:
Departement Neurologie en Nucleaire Geneeskunde Algemeen Ziekenhuis Middelheim, Antwerpen
F. Borggreve
Affiliation:
Departement Neurologie en Nucleaire Geneeskunde Algemeen Ziekenhuis Middelheim, Antwerpen
W. Spanoghe
Affiliation:
Departement Neurologie en Nucleaire Geneeskunde Algemeen Ziekenhuis Middelheim, Antwerpen
J. Saerens
Affiliation:
Departement Neurologie en Nucleaire Geneeskunde Algemeen Ziekenhuis Middelheim, Antwerpen
B.A. Pickut
Affiliation:
Departement Neurologie en Nucleaire Geneeskunde Algemeen Ziekenhuis Middelheim, AntwerpenNucleaire Geneeskunde Algemeen Ziekenhuis Middelheim, Antwerpen
P.P. De Deyn
Affiliation:
Departement Neurologie en Nucleaire Geneeskunde Algemeen Ziekenhuis Middelheim, AntwerpenDepartement Neurologie, Born-Bunge Instituut, Laboratorium Neurochemie en Gedrag, Universiteit Antwerpen
*
A.Z. Middelheim, Dienst Neurologie, Lindendreef 1, B-2020 Antwerpen, België

Summary

Due to abrupt interruption of hidden benzodiazepine-use, a 68-year-old woman developed a full-blown abstinence delirium characterized by epileptic seizures and progressive focal neurocognitive symptoms. The evolution of such rare neuro-linguistic phenomena as an echoism, palilalia and glossomania associated with a progressive visuo-perceptive syndrome and a visual hallucinosis are for the first time reported within the context of withdrawal. Notwithstanding the lack of any neuroradiological evidence for a morphological lesion in the clinically expected brain regions, the anatomo-clinical hypothesis of a focal frontal and parieto-occipital dysfunction was explicitly corroborated by repeated 99mTc-HMPAO SPECT findings.

Information

Type
Research Article
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable